| Original language | English |
|---|---|
| Pages (from-to) | 686-689 |
| Number of pages | 4 |
| Journal | American Journal of Kidney Diseases |
| Volume | 80 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Nov 2022 |
Bibliographical note
Funding Information:Research idea and study design: AXG, FKB, JMS, PJD; data acquisition: ANN, AO, AP, ARL, AS, AXG, BMB, CYW, EGF, FKB, GCAW, GS, JN, JSM, JTH, JV, KB, MB, MBC, MT, MTR, MU, PJD, PSancheti, PŚlęczka, RJ, RJF, SP, VH, VT, WS; data analysis/interpretation: AXG, FKB, JMS, KB, MC, PJD; statistical analysis: KB, MC; supervision or mentorship: AXG, FKB, JMD, PJD. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for their own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. A list of the HIP ATTACK-1 collaborators is in Item S3. This work was supported by the Canadian Institutes of Health Research (CIHR) Foundation Award, CIHR's Strategy for Patient-Oriented Research (SPOR), through the Ontario SPOR Support Unit (OSSU), as well as the Ontario Ministry of Health and Long-Term Care, and a grant from Smith & Nephew to recruit 300 patients in Spain. Grants to support this substudy were provided by the Department of Medicine at Western University. FKB holds a McMaster University Department of Medicine Career Research Award. PJD was supported by a Tier 1 Canada Research Chair in Perioperative Medicine. AXG was supported by the Dr Adam Linton Chair in Kidney Health Analytics and a CIHR Clinician Investigator Award. No funding entity had a role in data collection, statistical analysis, manuscript writing, or the decision to publish. The authors declare that they have no other relevant financial interests. The conduct, trial analyses, the composing of this manuscript, and its final contents are solely the authors’ incumbency. Received August 12, 2021. Evaluated by 2 external peer reviewers, with direct editorial input from a Statistics/Methods Editor, an Associate Editor, and the Editor-in-Chief. Accepted in revised form January 14, 2022.
Funding Information:
This work was supported by the Canadian Institutes of Health Research ( CIHR ) Foundation Award, CIHR’s Strategy for Patient-Oriented Research ( SPOR ), through the Ontario SPOR Support Unit (OSSU), as well as the Ontario Ministry of Health and Long-Term Care , and a grant from Smith & Nephew to recruit 300 patients in Spain. Grants to support this substudy were provided by the Department of Medicine at Western University . FKB holds a McMaster University Department of Medicine Career Research Award. PJD was supported by a Tier 1 Canada Research Chair in Perioperative Medicine. AXG was supported by the Dr Adam Linton Chair in Kidney Health Analytics and a CIHR Clinician Investigator Award. No funding entity had a role in data collection, statistical analysis, manuscript writing, or the decision to publish.
ASJC Scopus Subject Areas
- Nephrology
PubMed: MeSH publication types
- Randomized Controlled Trial
- Letter